Last updated 3 months ago

A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

240 patients around the world
Available in Spain, United States, Argentina
argenx
240Patients around the world

This study is for people with

Inflammatory Myopathies
Dermatomyositis

Requirements for the patient

From 18 Years
All Gender

Medical requirements

LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy